litlas
ログインアカウント作成

Thomas A. Buchholz

1980–2025 年に発表

175
論文数
35,432
被引用数
108
h 指数
175
i10 指数

被引用数

Thomas A. Buchholz の年別被引用数1974 年: 被引用 1 件1980 年: 被引用 2 件1981 年: 被引用 1 件1982 年: 被引用 1 件1984 年: 被引用 2 件1985 年: 被引用 4 件1986 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 5 件1989 年: 被引用 5 件1990 年: 被引用 7 件1991 年: 被引用 6 件1992 年: 被引用 5 件1993 年: 被引用 6 件1994 年: 被引用 10 件1995 年: 被引用 6 件1996 年: 被引用 12 件1997 年: 被引用 4 件1998 年: 被引用 7 件1999 年: 被引用 11 件2000 年: 被引用 24 件2001 年: 被引用 23 件2002 年: 被引用 55 件2003 年: 被引用 71 件2004 年: 被引用 125 件2005 年: 被引用 169 件2006 年: 被引用 195 件2007 年: 被引用 230 件2008 年: 被引用 220 件2009 年: 被引用 208 件2010 年: 被引用 314 件2011 年: 被引用 307 件2012 年: 被引用 293 件2013 年: 被引用 340 件2014 年: 被引用 353 件2015 年: 被引用 321 件2016 年: 被引用 321 件2017 年: 被引用 273 件2018 年: 被引用 243 件2019 年: 被引用 928 件2020 年: 被引用 906 件2021 年: 被引用 729 件2022 年: 被引用 515 件2023 年: 被引用 290 件2024 年: 被引用 480 件2025 年: 被引用 168 件2026 年: 被引用 5 件1975〜1979 年は被引用が無いため表示していません1983 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,416 件、この内訳の 32.5%中国: 引用元論文 720 件、この内訳の 6.9%イギリス: 引用元論文 583 件、この内訳の 5.5%イタリア: 引用元論文 500 件、この内訳の 4.8%ドイツ: 引用元論文 462 件、この内訳の 4.4%カナダ: 引用元論文 436 件、この内訳の 4.1%フランス: 引用元論文 423 件、この内訳の 4%オランダ: 引用元論文 368 件、この内訳の 3.5%オーストラリア: 引用元論文 244 件、この内訳の 2.3%ベルギー: 引用元論文 236 件、この内訳の 2.2%スペイン: 引用元論文 236 件、この内訳の 2.2%スイス: 引用元論文 228 件、この内訳の 2.2%
0%32.5%その他 25.4%

機関

分野

  • Medicine48.5%
  • Biochemistry, Genetics and Molecular Biology39.5%
  • Computer Science5.1%
  • Physics and Astronomy1.7%
  • Engineering1.1%
  • Immunology and Microbiology0.7%
  • その他3.4%

トピック

  • Breast Cancer Treatment Studies12.8%
  • Breast Lesions and Carcinomas5.4%
  • Breast Implant and Reconstruction4.2%
  • HER2/EGFR in Cancer Research3.5%
  • Cancer Cells and Metastasis2.4%
  • Advanced Breast Cancer Therapies1.9%
  • その他69.8%

共著者

全論文

検索で開く
  1. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

    著者: W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xianjun Yu, Ya Zhang, Mei Liu, Andrew F. Walls, Alex Bousamra, Maheshwari Ramineni, Bruno V. Sinn, Kelly K. Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy L. Moulder, Lajos Pusztai, Christos Hatzis, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2017 被引用: 718

  2. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

    著者: Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen A. Gelmon, Sharon H. Giordano, Clifford A. Hudis, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2018 被引用: 630

  3. Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

    著者: Benjamin D. Smith, Grace L. Smith, Arti Hurria, Gabriel N. Hortobágyi, Thomas A. Buchholz - Journal of Clinical Oncology 2009 被引用: 1,727

  4. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

    著者: Sarah S. Mougalian, Mike Hernández, Xiudong Lei, Siobhan P. Lynch, Henry M. Kuerer, W. Fraser Symmans, Richard L. Theriault, Bruno D. Fornage, Limin Hsu, Thomas A. Buchholz, Ayşegül A. Şahin, Kelly K. Hunt, Wei Yang, Gabriel N. Hortobágyi, Vicente Valero - JAMA Oncology 2015 被引用: 162

  5. Variability of Target and Normal Structure Delineation for Breast Cancer Radiotherapy: An RTOG Multi-Institutional and Multiobserver Study

    著者: X. Allen Li, A. Tai, Douglas W. Arthur, Thomas A. Buchholz, Shannon M. MacDonald, Lawrence B. Marks, Jean M. Moran, Lori J. Pierce, Rachel Rabinovitch, Alphonse G. Taghian, Frank A. Vicini, Wendy A. Woodward, Julia White - International Journal of Radiation Oncology*Biology*Physics 2009 被引用: 380

  6. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    著者: Henry M. Kuerer, Lisa A. Newman, Terry L. Smith, Fred C. Ames, Kelly K. Hunt, Kapil Dhingra, Richard L. Theriault, Gurpreet Singh, Susan M. Binkley, Nour Sneige, Thomas A. Buchholz, Merrick I. Ross, Marsha D. McNeese, Aman U. Buzdar, Gabriel N. Hortobágyi, S. Eva Singletary - Journal of Clinical Oncology 1999 被引用: 1,337

  7. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

    著者: Harold J. Burstein, Sarah Temin, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen Gelmon, Sharon H. Giordano, Clifford A. Hudis, Diana Rowden, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2014 被引用: 793

  8. Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study

    著者: Ya‐Chen Tina Shih, Ying Xu, Janice N. Cormier, Sharon H. Giordano, Sheila H. Ridner, Thomas A. Buchholz, George H. Perkins, Linda S. Elting - Journal of Clinical Oncology 2009 被引用: 493

  9. Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

    著者: Reshma Jagsi, Manjeet Chadha, Janaki Moni, Karla V. Ballman, Fran Laurie, Thomas A. Buchholz, Armando E. Giuliano, Bruce G. Haffty - Journal of Clinical Oncology 2014 被引用: 392

  10. Trends and Variation in Use of Breast Reconstruction in Patients With Breast Cancer Undergoing Mastectomy in the United States

    著者: Reshma Jagsi, Jing Jiang, Adeyiza O. Momoh, Amy K. Alderman, Sharon H. Giordano, Thomas A. Buchholz, Steven J. Kronowitz, Benjamin D. Smith - Journal of Clinical Oncology 2014 被引用: 442

  11. MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells

    著者: Kathleen A. Bridges, Hiroshi Hirai, Carolyn A. Buser, Colin Brooks, Huifeng Liu, Thomas A. Buchholz, Jessica M. Molkentine, Kathryn A. Mason, Raymond E. Meyn - Clinical Cancer Research 2011 被引用: 234

  12. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

    著者: Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen Gelmon, Sharon H. Giordano, Clifford A. Hudis, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2016 被引用: 303

  13. Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    著者: Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis, Daniel J. Booser, Eva Thomas, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, Banu Arun, Sharon H. Giordano, Massimo Cristofanilli, Debra Frye, Terry L. Smith, Kelly K. Hunt, S. Eva Singletary, Ayşegül A. Şahin, Michael S. Ewer, Thomas A. Buchholz, Donald A. Berry, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2005 被引用: 1,170

  14. WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells

    著者: Wendy A. Woodward, Mercy S. Chen, Fariba Behbod, Maria P. Alfaro, Thomas A. Buchholz, Jeffrey M. Rosen - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 600

  15. High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

    著者: Ana M. González-Angulo, Jennifer K. Litton, Kristine Broglio, Funda Meric‐Bernstam, Ronjay Rakkhit, Fátima Cardoso, Florentia Peintinger, Emer O. Hanrahan, Ayşegül A. Şahin, Merih Güray, Denis Larsimont, Francesco Feoli, Heidi Stranzl, Thomas A. Buchholz, Vicente Valero, Richard L. Theriault, Martine Piccart, Peter M. Ravdin, Donald A. Berry, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2009 被引用: 467

  16. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation

    著者: Simona F. Shaitelman, Pamela J. Schlembach, Isidora Arzu, Matthew T. Ballo, Elizabeth S. Bloom, D. Buchholz, Gregory M. Chronowski, Tomáš Dvořák, Emily Grade, Karen E. Hoffman, Patrick Kelly, Michelle Ludwig, George H. Perkins, Valerie Reed, Shalin Shah, Michael C. Stauder, Eric A. Strom, Welela Tereffe, Wendy A. Woodward, Joe Ensor, Donald P. Baumann, Alastair M. Thompson, Diana Amaya, Tanisha Davis, William Guerra, Lois Hamblin, Gabriel N. Hortobágyi, Kelly K. Hunt, Thomas A. Buchholz, Benjamin D. Smith - JAMA Oncology 2015 被引用: 265

  17. Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer

    著者: Roman Rouzier, Radhika Rajan, Peter J. Wagner, Kenneth R. Hess, David Gold, James Stec, Mark Ayers, Jeffrey S. Ross, Peter Zhang, Thomas A. Buchholz, Henry M. Kuerer, Marjorie Green, Banu Arun, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 被引用: 411

  18. Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy

    著者: Grace L. Smith, Benjamin D. Smith, Thomas A. Buchholz, Sharon H. Giordano, Adam S. Garden, Wendy A. Woodward, Harlan M. Krumholz, Randal S. Weber, K. Kian Ang, David I. Rosenthal - Journal of Clinical Oncology 2008 被引用: 231

  19. Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

    著者: Valentina Guarneri, Kristine Broglio, Shu‐Wan Kau, Massimo Cristofanilli, Aman U. Buzdar, Vicente Valero, Thomas A. Buchholz, Funda Meric, Lavinia P. Middleton, Gabriel N. Hortobágyi, Ana M. González-Angulo - Journal of Clinical Oncology 2006 被引用: 602

  20. Delayed-Immediate Breast Reconstruction

    著者: Steven J. Kronowitz, Kelly K. Hunt, Henry M. Kuerer, Gildy V. Babiera, Marsha D. McNeese, Thomas A. Buchholz, Eric A. Strom, Geoffrey L. Robb - Plastic & Reconstructive Surgery 2004 被引用: 383

  21. Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

    著者: Mariana Chávez‐MacGregor, Ning Zhang, Thomas A. Buchholz, Yufeng Zhang, Jiangong Niu, Linda S. Elting, Benjamin D. Smith, Gabriel N. Hortobágyi, Sharon H. Giordano - Journal of Clinical Oncology 2013 被引用: 240

  22. Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

    著者: Elizabeth A. Mittendorf, Jacqueline S. Jeruss, Susan L. Tucker, Aparna Kolli, Lisa A. Newman, Ana M. González-Angulo, Thomas A. Buchholz, Ayşegül A. Şahin, Janice N. Cormier, Aman U. Buzdar, Gabriel N. Hortobágyi, Kelly K. Hunt - Journal of Clinical Oncology 2011 被引用: 182

  23. Inflammatory Breast Cancer: The Disease, the Biology, the Treatment

    著者: Fredika M. Robertson, Melissa L. Bondy, Wei Yang, Hideko Yamauchi, Shannon Wiggins, Samira Kamrudin, Savitri Krishnamurthy, Huong T. Le‐Petross, Luc Bidaut, Audrey Player, Sanford H. Barsky, Wendy A. Woodward, Thomas A. Buchholz, Anthony Lucci, Naoto T. Ueno, Massimo Cristofanilli - CA A Cancer Journal for Clinicians 2010 被引用: 368

  24. Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols

    著者: Amit Garg, Thomas A. Buchholz, Bharat B. Aggarwal - Antioxidants and Redox Signaling 2005 被引用: 278